Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway | |
Fan, Hongjun; Yu, Xiying; Zou, Zhigeng; Zheng, Wei; Deng, Xin; Guo, Liping; Jiang, Wei; Zhan, Qimin; Lu, Shih-Hsin | |
2019 | |
卷号 | 40期号:5页码:669-679 |
ISSN号 | 0143-3334 |
DOI | 10.1093/carcin/bgy160 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6345755 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Fan, Hongjun,Yu, Xiying,Zou, Zhigeng,et al. Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway[J],2019,40(5):669-679. |
APA | Fan, Hongjun.,Yu, Xiying.,Zou, Zhigeng.,Zheng, Wei.,Deng, Xin.,...&Lu, Shih-Hsin.(2019).Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway.,40(5),669-679. |
MLA | Fan, Hongjun,et al."Metformin suppresses the esophageal carcinogenesis in rats treated with NMBzA through inhibiting AMPK/mTOR signaling pathway".40.5(2019):669-679. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论